241 related articles for article (PubMed ID: 12612811)
1. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study.
Maza S; Valencia R; Geworski L; Zander A; Guski H; Winzer KJ; Munz DL
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):651-6. PubMed ID: 12612811
[TBL] [Abstract][Full Text] [Related]
2. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
[TBL] [Abstract][Full Text] [Related]
3. Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions.
De Cicco C; Trifirò G; Intra M; Marotta G; Ciprian A; Frasson A; Prisco G; Luini A; Viale G; Paganelli G
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):349-54. PubMed ID: 14647985
[TBL] [Abstract][Full Text] [Related]
4. [Subareolar injection of 99m-Tc sulfur colloid for sentinel nodes identification in multifocal invasive breast cancer].
Mertz L; Mathelin C; Marin C; Gairard B; Chenard MP; Brettes JP; Bellocq JP; Constantinesco A
Bull Cancer; 1999 Nov; 86(11):939-45. PubMed ID: 10586110
[TBL] [Abstract][Full Text] [Related]
5. Use of Tc99m-nanocolloid for sentinel nodes identification in cervical cancer.
Hubalewska A; Sowa-Staszczak A; Huszno B; Markocka A; Pityński K; Basta A; Opławski M; Basta P
Nucl Med Rev Cent East Eur; 2003; 6(2):127-30. PubMed ID: 14737727
[TBL] [Abstract][Full Text] [Related]
6. Lymphoscintigraphy in breast cancer patients--comparison of peritumoural and intradermal injection.
Rettenbacher L; Kässmann H; Galvan G; Menzel C; Reitsamer R; Holzmannhofer J
Nuklearmedizin; 2000 Sep; 39(6):152-5. PubMed ID: 11057406
[TBL] [Abstract][Full Text] [Related]
7. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
[TBL] [Abstract][Full Text] [Related]
8. Subareolar injection for sentinel lymph node location in breast cancer.
Zavagno G; Meggiolaro F; Rossi CR; Casara D; Pescarini L; Marchet A; Denetto V; Baratella P; Lise M
Eur J Surg Oncol; 2002 Nov; 28(7):701-4. PubMed ID: 12431465
[TBL] [Abstract][Full Text] [Related]
9. Subdermal re-injection: a method to increase surgical detection of the sentinel node in breast cancer without increasing the false-negative rate.
Bajén MT; Benítez A; Mora J; Ricart Y; Ferran N; Guirao S; Carrera D; Gil M; Pla MJ; Gumá A; Palacin JA; Martin-Comin J
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):338-43. PubMed ID: 16307292
[TBL] [Abstract][Full Text] [Related]
10. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E; Sedlmayer F
World J Surg; 2003 Dec; 27(12):1291-4. PubMed ID: 14574485
[TBL] [Abstract][Full Text] [Related]
11. [Subareolar injection: a potential cause of false negative in the selective biopsy of the sentinel node in breast cancer].
Rioja Martín ME; Ortega Pérez G; Cabañas Montero LJ; Muñoz-Madero V; Cabañas Navarro L
Rev Esp Med Nucl; 2011; 30(4):251-3. PubMed ID: 21440959
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy in breast cancer patients: subdermal versus peritumoural radiocolloid injection.
Mateos JJ; Vidal-Sicart S; Zanón G; Pahisa J; Fuster D; Martín F; Ortega M; Fernández P; Pons F
Nucl Med Commun; 2001 Jan; 22(1):17-24. PubMed ID: 11233547
[TBL] [Abstract][Full Text] [Related]
13. [Intratumoral versus subareolar injection in breast cancer sentinel lymph node biopsy. A case report].
Lanchas Alfonso I; Miguel Martínez MB; CuezvaGuzmán JF; Rupérez Arribas P; Martínez Blanco S; Yartu San Millán JM; Duque Gallo JJ
Rev Esp Med Nucl; 2011; 30(3):171-3. PubMed ID: 21342723
[TBL] [Abstract][Full Text] [Related]
14. [Sentinel lymph node biopsy in breast cancer. Experience of the Rome Breast Cancer Study Group].
Fortunato L; Drago S; Vitelli CE; Santoni M; Gucciardo G; Cabassi A; Farina M; La Pinta M; Remedi M; Pagano G; Silipod T; Terribile D; Stagnitto D; Grassi GB;
Chir Ital; 2006; 58(6):689-96. PubMed ID: 17190273
[TBL] [Abstract][Full Text] [Related]
15. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
16. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT.
Brouwer OR; Buckle T; Vermeeren L; Klop WM; Balm AJ; van der Poel HG; van Rhijn BW; Horenblas S; Nieweg OE; van Leeuwen FW; Valdés Olmos RA
J Nucl Med; 2012 Jul; 53(7):1034-40. PubMed ID: 22645297
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node detection using 99mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study.
Koizumi M; Nomura E; Yamada Y; Takiguchi T; Tanaka K; Yoshimoto M; Makita M; Sakamoto G; Kasumi F; Ogata E
Nucl Med Commun; 2003 Jun; 24(6):663-70. PubMed ID: 12766602
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node identification with radiopharmaceuticals in patients with breast cancer: a comparison of 99mTc-tin colloid and 99mTc-phytate efficiency.
Seok JW; Choi YS; Chong S; Kwon GY; Chung YJ; Kim BG; Park SJ
Breast Cancer Res Treat; 2010 Jul; 122(2):453-7. PubMed ID: 20532977
[TBL] [Abstract][Full Text] [Related]
19. Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern? Results of a Dutch multicentre study (MULTISENT).
Brouwer OR; Vermeeren L; van der Ploeg IM; Valdés Olmos RA; Loo CE; Pereira-Bouda LM; Smit F; Neijenhuis P; Vrouenraets BC; Sivro-Prndelj F; Jap-a-Joe SM; Borgstein PJ; Rutgers EJ; Oldenburg HS
Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1137-43. PubMed ID: 22526968
[TBL] [Abstract][Full Text] [Related]
20. A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye.
Brouwer OR; van den Berg NS; Mathéron HM; van der Poel HG; van Rhijn BW; Bex A; van Tinteren H; Valdés Olmos RA; van Leeuwen FW; Horenblas S
Eur Urol; 2014 Mar; 65(3):600-9. PubMed ID: 24355132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
